Friday, May 28, 2010

Human Genomic Timeline

1800s

1859: Darwin publishes On the Origin of Species, proposing continual evolution of species
1865: Mendel's Peas
1869: DNA First Isolated
1879: Mitosis Observed


1900s

1900: Rediscovery of Mendel's work
1902: Orderly Inheritance of Disease Observed
1902: Chromosome Theory of Heredity
1909: The Word Gene Coined
1911: Fruit Flies Illuminate the Chromosome Theory


1940's

1941: One Gene, One Enzyme
1943: X-ray Diffraction of DNA
1944: DNA is "Transforming Principle"
1944: Jumping Genes


1950's

1952: Genes are Made of DNA
1953: DNA Double Helix
1955: 46 Human Chromosomes
1955: DNA Copying Enzyme
1956: Cause of Disease Traced to Alteration
1958: Semiconservative Replication of DNA
1959: Chromosome Abnormalities Identified


1960's

1961: mRNA Ferries Information
1961: First Screen for Metabolic Defect in Newborns
1966: Genetic Code Cracked
1968: First Restriction Enzymes Described


1970's

1972: First Recombinant DNA
1973: First Animal Gene Cloned
1975-77: DNA Sequencing
1976: First Genetic Engineering Company
1977: Introns Discovered


1980's

1981-82: First Transgenic Mice and Fruit Flies
1982: GenBank Database Formed
1983: First Disease Gene Mapped
1983: PCR Invented
1986: First Time Gene Positionally Cloned
1987: First Human Genetic Map
1987: YACs Developed
1989: Microsatelites, New Genetic Markers
1989: Sequence-tagged Sites, Another Marker


1990's

1990-1994

1990: Launch of the Human Genome Project
1990: ELSI Founded
1990: Research on BACs
1991: ESTs, Fragments of Genes
1992: Second-generation Genetic Map of Human Genome
1992: Data Release Guidelines Established
1993: NEW HGP Five-year Plan
1994: FLAVR SAVR Tomato
1994: Detailed Human Genetic Map
1994: Microbial Genome Project

1995-1996

1995: Ban on Genetic Discrimination in Workplace
1995: Two Microbial Genomes Sequenced
1995: Physical Map of Human Genome Completed
1996: International Strategy Meeting on Human Genome Sequencing
1996: Mouse Genetic Map Completed
1996: Yeast Genome Sequenced
1996: Archaea Genome Sequenced
1996: Health Insurance Discrimination Banned
1996: 280,000 Expressed Sequence Tags (ESTs)
1996: Human Gene Map Created
1996: Human DNA Sequence Begins

1997-1999

1997: Bermuda Meeting Affirms Principle of Data Release
1997: E. coli Genome Sequenced
1997: Recommendations on Genetic Testing
1998: Private Company Announces Sequencing Plan
1998: M. Tuberculosis Bacterium Sequenced
1998: Committee on Genetic Testing
1998: HGP Map Includes 30,000 Human Genes
1998: New HGP Goals for 2003
1998: SNP Initiative Begins
1998: Genome of Roundworm C. elegans Sequenced
1999: Full-scale Human Genome Sequencing
1999: Chromosome 22


2000 - 2001

2000: Free Access to Genomic Information
2000: Chromosome 21
2000: Working Draft
2000: Drosophila and Arabidopsis genomes sequenced
2000: Executive Order Bans Genetic Descrimination in the Federal Workplace
2000: Yeast Interactome Published
2000: Fly Model of Parkinson's Disease Reported
2001: First Draft of the Human Genome Sequence Released
2001: RNAi Shuts Off Mammalian Genes
2001: FDA Approves Genetics-based Drug to Treat Leukemia


2002 -2003

2002: Mouse Genome Sequenced
2002: Researchers Find Genetic Variation Associated with Prostate Cancer
2002: Rice Genome Sequenced
2002: The International HapMap Project is Announced
2002: The Genomes to Life Program is Launched
2002: Researchers Identify Gene Linked to Bipolar Disorder
2003: Human Genome Project Completed
2003: Fiftieth Anniversary of Watson and Crick's Description of the Double Helix
2003: The First National DNA Day Celebrated
2003: ENCODE Program Begins
2003: Premature Aging Gene Identified


2004 - The Future

2004: Rat and Chicken Genomes Sequenced
2004: FDA Approves First Microarray
2004: Refined Analysis of Complete Human Genome Sequence
2004: Surgeon General Stresses Importance of Family History
2005: Chimpanzee Genomes Sequenced
2005: HapMap Project Completed
2005: Trypanosomatid Genomes Sequenced
2005: Dog Genomes Sequenced
2006: The Cancer Genome Atlas (TCGA) Project Started
2006: Second Non-human Primate Genome is Sequenced
2006: Initiatives to Establish the Genetic and Environmental Causes of Common Diseases Launched

Source: http://www.genome.gov/

National Human Genome Research Institute


Thursday, May 20, 2010

Study of Antibacterial properties of Actinomycetes isolates from hospital waste

Study of Antibacterial properties of Actinomycetes isolates from hospital waste


Research Students:

A.B

Universal Science College, Department of Biochemistry

Pokhara University

Supervisor:

Upendra Thapa Shrestha

Assistant professor

Universal Science College, Department of Biochemistry

Pokhara University

1. Introduction

Actinomycetes comprise an extensive and diverse group of Gram-positive, aerobic, mycelial bacteria with high G+C nucleotide content (>55%), and play an important ecological role in soil cycle. The name of the group actinomycetes is derived from the first described anaerobic species Actinomyces bovis that causes actinomycosis, the ‘ray-fungus disease’ of cattle. They were originally considered to be intermediate group between bacteria and fungi but are now recognized as prokaryotic microorganisms (Kuster 1968).

The majority of Actinomycetes are free living, saprophytic bacteria found widely distributed in soil, water and colonizing plants. Actinomycetes population has been identified as one of the major group of soil population (Kuster 1968), which may vary with the soil type. They belong to the order Actinomycetales (Superkingdom: Bacteria, Phylum: Firmicutes, Class: Actinobacteria, Subclass: Actinobacteridae). According to Bergey's Manual Actinomycetes are divided into eight diverse families: Actinomycetaceae, Mycobacteriaceae, Actinoplanaceae, Frankiaceae, Dermatophilaceae, Nocardiaceae, Streptomycetaceae, Micromonosporaceae (Holt, 1989) and they comprise 63 genera (Nisbet and Fox, 1991). Based on 16s rRNA classification system they have recently been grouped in ten suborders: Actinomycineae, Corynebacterineae, Frankineae, Glycomycineae, Micrococineae, Micromonosporineae, Propionibacterineae, Pseudonocardineae, Streptomycineae and a large member of Streptomyces are still remained to be grouped (www.ncbi.nlm.nih.gov). Actinomycetes have characteristic biological aspects such as mycelial forms of growth that accumulates in sporulation and the ability to form a wide variety of secondary metabolites including most of the antibiotics.

One of the major groups in actinomycetes is Streptomyces. Streptomyces contains 69-78 mol% of G+C. Substrate and aerial mycelium is highly branched. Substrate hyphae are 0.5-1.0 µm in diameter. In the colony ages aerial mycelia develop into chain of spores (conidia) by the formation of crosswalls in the multinucleated aerial filaments. Conidial wall are convoluted projection which together with the shape and the arrangement of the spore-bearing structure are characteristic of each species of Streptomyces (Anderson et al., 2001). It produces several antibiotics including of aminoglycosides, anthracyclins, glycopeptides, b-lactams, macrolides, nucleosides, peptides, polyenes, polyethers and tetracyclines (Sahin and Ugur, 2003).

Thus investigators turn towards Streptomyces and also other genera of actinomycetes such as Nocardia, Micromonospora, Thermoactinomycetes etc. for isolation of novel antibiotics. No doubt soil is the natural habitat of most of the microorganisms where vast array of bacteria, actinomycetes, fungi and other organisms exist and provided with suitable growth condition and ability to proliferate. Thus most actinomycetes contributing to antibiotic production are screened from soil (Williams and Khan, 1974).

Our prime focus is to find out the novel antibiotic with broad-spectrum antimicrobial activity from Actinomyecetes isolates of hospital waste.

2. Background

In, RLABB, The first work on the diversity of actinomycestes was started by Singh, D. and Agrawal, V.P. (2002). The research on actinomycetes form Mount Everest was then continued by Pandey, B., Ghimire, P. and Agrawal, V.P. (2004). Still the work is conducting by Baniya R, Guragain M, Sherpa C and Gurung T. Baniya found many actinomycetes with broad-spectrum antimicrobial activity. Among them most of actinomycetes are Streptomyces. Although more research has been done on actinomycetes and antibiosis from Khumbu region, none of the research regarding actinomycetes isolates from hospital waste was yet done. Hence the study will explore about the antibacterial properties of actinomycetes isolates from hospital waste to have significant antibiotics against the clinically important bacteria.

3. Objectives

1. To collect and isolate actinomycetes from the hospital waste samples.

2. To purify and identify the actinomycetes isolates.

3. To screen the actinomycetes isolates for antibiotic production by primary and secondary screening methods.

4. Hypotheses

It is hypothesized that Actinomycetes from hospital waste may have developed broad spectrum antibiotic producing properties during their continuous interaction with different types of clinically important bacteria in their natural niche. Therefore the actinomycetes isolates from such habitat may be of great importance in medical field.

5. Methodology

5.1. Isolation and Purification of Actinomycetes

Hospital waste samples will be collected from different hospital waste dumping sites in plastic pouches, sealed and transferred to Research Laboratory of Universal Science College where entire research work will be carried out. Isolation of actinomycetes will be performed by dilution plate technique using Starch-Casein Agar (Singh and Agrawal, 2002 & 2003). Actinomycetes on the plates will be identified as colored, dried, rough, with irregular/regular margin; generally convex colony as described by Williams and Cross (1971). Streak plate method will be used to purify cultures of actinomycetes (Williams and Cross, 1971, Singh and Agrawal 2002; Agrawal 2003). After isolation of the pure colonies, each different cology will be identified on the basis on their colonial morphology, colour of hyphae, color of aerial mycelium and microscopy. Then they will be individually plated on single same agar medium for short time preservation.

5.2. Morphological and Biochemical characterization

Morphological examination of the actinomycetes will be done by using cellophane tape and cover slip-buried methods (Williams and Cross, 1971; Singh and Agrawal 2002; Singh and Agrawal 2003). The mycelium structure, color and arrangement of conidiophores and arthrospore on the mycelium will be examined under oil immersion (1000X). The observed structure will be compared with Bergay’s manual of Determinative Bacteriology, Ninth edition (2000) for identification Streptomyces spp. Different biochemical tests will be performed to characterize the Streptomyces spp. The tests generally used are gelatin hydrolysis, starch hydrolysis, urea- hydrolysis, acid production from different sugars utilization tests, resistance to NaCl, temperature tolerance test, hydrogen sulphide production test, motility test, triple sugar iron (TSI) agar test, citrate utilization test, indole test, methyl red test, voges-proskauer (Acetoin Production) test, catalase test, oxidase test (Holt 1989; Singh and Agrawal 2002; Singh and Agrawal 2003).

5.3. Screening of Actinomycetes for antimicrobial activity

5.3.1 Primary screening:

Primary screening of pure isolates will be determined by perpendicular streak method on Muller Hinton agar (MHA). In vitro screening of isolates for antagonism: MHA on Nutrient Agar (NA) plates will be prepared and inoculated with Actinomycetes isolate by a single streak of inoculum in the center of the petridish. After 4 days of incubation at 28 °C the plates were seeded with test organisms (Bacillus subtilis, Staphylococcus aureus, Enterobacter aerogens, Escherichia coli, Klebsiella species, Proteus species, Pseudomonas species, Salmonella typhi and Shigella species) by a single streak at a 90° angle to Actinomycetes strains. The microbial interactions were analyzed by the determination of the size of the inhibition zone.

5.3.2 Secondary screening:

Secondary screening is performed by agar well method against the standard test organism. Fresh and pure culture of each strain from the primary screening will be inoculated in starch casein broth and incubated at accordingly for 7 days in water bath shaker. The visible pellets, clumps or aggregates and turbidity in the broth, will confirm growth of the organism in the flask. Contents of flasks will be filtered through Whatman no.1 filter paper. The filtrate will be used for the determination of antimicrobial activity against the standard test organisms by agar well method.

6. Expected Outcomes

Being majority of antibiotics producing bacteria are Actinomycetes (mainly Streptomyces spp.) our research work will select different actinomycetes producing only broad-spectrum antibiotics effective against the clinically important bacteria. The actinomycetes will be screened by both primary and secondary screening methods. Any of potent strain from such sample will be further studied.

7. References

Anderson AS and Wellington EMH (2001) The taxonomy of Streptomyces and related genera. Int J Syst Evol Microbiol 51:797–814

Holt JG 1989 Bergey's manual of systematic bacteriology, vol 4, ed. S.T. Williams and M.E. Sharpe, Baltimore, Md: Williams and Williams.

Kuster HJ, (1968) Uber die Bildung Von Huminstoffen durch Streptomyceten. Landwirtsch. Forsch 21:48-61

Nisbet LJ and Fox FM (1991) The importance of microbial biodiversity to biotechnology, In, The biodiversity of microorganisms and invertebrates: its role in sustainable Agriculture, ed.D.L. Hawksworth, 224-229, CAB International.

Pandey B, Ghimire P and Agrawal VP (2004) Studies on Antibacterial Activity of Soil from Khumbu Region of Mount Everest, a paper presented in International Conference on The Great Himalayas Climate, Health, Ecology, Management and Conservation, Kathmandu, January 12-15

Sahin N and Ugur A (2003) Investigation of the Antimicribial Activity of some Streptomyces isolates. Turk J Biol 27: 79-84.

Singh D and Agrawal VP (2002) Microbial Biodiversity of Mount Everest Region, a paper presented in International Seminar on Mountains - Kathmandu, March 6 – 8 (organized by Royal Nepal Academy of Science and Technology)

Singh D and Agrawal VP (2003) Diversity of Actinomycetes of Lobuche in Mount Everest I Proceedings of International Seminar on Mountains – Kathmandu: March 6 – 8, 2002 pp. 357 – 360.

Williams ST and Cross T (1971) Actinomycetes. In: J.R. Norris, D. W. Robbins, (eds), Methods in microbiology, vol.4. London, 295-334, Academic Perss, NewYork.

Wednesday, May 19, 2010

Characterization of broad spectrum antibiotics from Actinomycetes isolates from Khumbu region for the search of novel ones.

Proposal on

Characterization of broad spectrum antibiotics from Actinomycetes isolates from Khumbu region for the search of novel ones.

Introduction

Actinomycetes comprise an extensive and diverse group of Gram-positive, aerobic, mycelial bacteria with high G+C nucleotide content (>55%), and play an important ecological role in soil cycle. The name of the group actinomycetes is derived from the first described anaerobic species Actinomyces bovis that causes actinomycosis, the ‘ray-fungus disease’ of cattle. They were originally considered to be intermediate group between bacteria and fungi but are now recognized as prokaryotic microorganisms (Kuster 1968).

The majority of Actinomycetes are free living, saprophytic bacteria found widely distributed in soil, water and colonizing plants. Actinomycetes population has been identified as one of the major group of soil population (Kuster 1968), which may vary with the soil type. They belong to the order Actinomycetales (Superkingdom: Bacteria, Phylum: Firmicutes, Class: Actinobacteria, Subclass: Actinobacteridae). According to Bergey's Manual Actinomycetes are divided into eight diverse families: Actinomycetaceae, Mycobacteriaceae, Actinoplanaceae, Frankiaceae, Dermatophilaceae, Nocardiaceae, Streptomycetaceae, Micromonosporaceae (Holt, 1989) and they comprise 63 genera (Nisbet and Fox, 1991). Based on 16s rRNA classification system they have recently been grouped in ten suborders: Actinomycineae, Corynebacterineae, Frankineae, Glycomycineae, Micrococineae, Micromonosporineae, Propionibacterineae, Pseudonocardineae, Streptomycineae and a large member of Streptomyces are still remained to be grouped (www.ncbi.nlm.nih.gov). Actinomycetes have characteristic biological aspects such as mycelial forms of growth that accumulates in sporulation and the ability to form a wide variety of secondary metabolites including most of the antibiotics.

One of the major groups in actinomycetes is Streptomyces. Streptomyces contains 69-78 mol% of G+C. Substrate and aerial mycelium is highly branched. Substrate hyphae are 0.5-1.0 µm in diameter. In the colony ages aerial mycelia develop into chain of spores (conidia) by the formation of crosswalls in the multinucleated aerial filaments. Conidial wall are convoluted projection which together with the shape and the arrangement of the spore-bearing structure are characteristic of each species of Streptomyces (Anderson et al., 2001). It produces several antibiotics including of aminoglycosides, anthracyclins, glycopeptides, b-lactams, macrolides, nucleosides, peptides, polyenes, polyethers and tetracyclines (Sahin and Ugur, 2003).

Thus investigators turn towards Streptomyces and also other genera of actinomycetes such as Nocardia, Micromonospora, Thermoactinomycetes etc. for isolation of novel antibiotics. No doubt soil is the natural habitat of most of the microorganisms where vast array of bacteria, actinomycetes, fungi and other organisms exist and provided with suitable growth condition and ability to proliferate. Thus most actinomycetes contributing to antibiotic production are screened from soil (Williams and Khan, 1974).

Our prime focus is to find out the novel antibiotic with broad-spectrum antimicrobial activity from Actinomyecetes isolates of high altitude.

Background

In, RLABB, The first work on the diversity of actinomycestes was started by Singh, D. and Agrawal, V.P. (2002). The research on actinomycetes form Mount Everest was then continued by Pandey, B., Ghimire, P. and Agrawal, V.P. (2004). Still the work is conducting by Baniya R, Guragain M, Sherpa C and Gurung T. Baniya found many actinomycetes with broad-spectrum antimicrobial activity. Among them most of actinomycetes are Streptomyces. Although more research has been done on antibiosis, classification of antibiotic groups has not yet done due to lack of advanced technology. Hence the study will explore more about the chemical property of antibiotics produced by them using GC analysis and some other advanced techniques if required during the antibiotic characterization

Objectives

1. To subculture actinomycetes isolates which are already present in RLABB

2. To screen for antibiotic production

3. To partially purify the antibiotics

4. To characterize the antibiotics by GC analysis

Methodology

1. Isolation and Purification of Actinomycetes

Soil samples will be obtained from Research Laboratory for Agricultural Biotechnology and Biochemistry (RLABB). Isolation of actinomycetes will be performed by soil dilution plate technique using Starch-Casein Agar (Singh and Agrawal, 2002 & 2003). Actinomycetes on the plates will be identified as colored, dried, rough, with irregular/regular margin; generally convex colony as described by Williams and Cross (1971). Streak plate method will be used to purify cultures of actinomycetes (Williams and Cross, 1971, Singh and Agrawal 2002; Agrawal 2003). After isolation of the pure colonies based on their colonial morphology, colour of hyphae, color of aerial mycelium, they will be individually plated on another but the same agar medium.

2. Morphological and Biochemical characterization

Morphological examination of the actinomycetes will be done by using cellophane tape and cover slip-buried methods (Williams and Cross, 1971; Singh and Agrawal 2002; Singh and Agrawal 2003). The mycelium structure, color and arrangement of conidiophores and arthrospore on the mycelium will be examined under oil immersion (1000X). The observed structure will be compared with Bergay’s manual of Determinative Bacteriology, Ninth edition (2000) for identification Streptomyces spp. Different biochemical tests will be performed to characterize the Streptomyces spp. The tests generally used are gelatin hydrolysis, starch hydrolysis, urea- hydrolysis, acid production from different sugars utilization tests, resistance to NaCl, temperature tolerance test, hydrogen sulphide production test, motility test, triple sugar iron (TSI) agar test, citrate utilization test, indole test, methyl red test, voges-proskauer (Acetoin Production) test, catalase test, oxidase test (Holt 1989; Singh and Agrawal 2002; Singh and Agrawal 2003).

3. Screening of Actinomycetes for antimicrobial activity

3.1 Primary screening:

Primary screening of pure isolates will be determined by perpendicular streak method on Muller Hinton agar (MHA). In vitro screening of isolates for antagonism: MHA on Nutrient Agar (NA) plates will be prepared and inoculated with Actinomycetes isolate by a single streak of inoculum in the center of the petridish. After 4 days of incubation at 28 °C the plates were seeded with test organisms (Bacillus subtilis, Staphylococcus aureus, Enterobacter aerogens, Escherichia coli, Klebsiella species, Proteus species, Pseudomonas species, Salmonella typhi and Shigella species) by a single streak at a 90° angle to Actinomycetes strains. The microbial interactions were analyzed by the determination of the size of the inhibition zone.

3.2 Secondary screening:

Secondary screening is performed by agar well method against the standard test organism. Fresh and pure culture of each strain from the primary screening will be inoculated in starch casein broth and incubated at accordingly for 7 days in water bath shaker. The visible pellets, clumps or aggregates and turbidity in the broth, will confirm growth of the organism in the flask. Contents of flasks will be filtered through Whatman no.1 filter paper. The filtrate will be used for the determination of antimicrobial activity against the standard test organisms by agar well method.

4. Antibiotics Fermentation process

Isolates showing the broad-spectrum antimicrobial activity are grown in submerged culture in 250 ml flasks containing 50 ml of broth describe in Sahin & Ugur, 2003. The flasks are inoculated with 1ml of active Actinomycetes culture and incubated at 28ºc for 7 days with shaking at 500 rpm. After fermentation, fermented broth will filtered through Whatman no.1 filter paper.

5. Extraction of antimicrobial metabolites

Antibacterial compound will be recovered from the filtrate by treating twice with one volume of ethyl acetate (Busti et al., 2006). And after evaporation residue will be used for determination of antimicrobial activity, minimum inhibitory concentration and to perform bioassay of antibiotic (Pandey et al., 2004).

6. Thin Layer Chromatography and Bioassay of antibiotic

Silica gel plates, 10 X 20 cm, 1mm thick, are prepared. They are activated at 150°C for half an hour. Ten micro-liters of the ethyl acetate fractions and reference antibiotics are applied on the plates and the chromatogram is developed using chloroform: methanol (4:1) as solvent system. The plates are run in duplicate; one set is used as the reference chromatogram and the other is used for Bioassay of antibiotic. The spots in the chromatogram are visualized in the iodine vapor chamber and UV chamber (Thangadural et al., 2002 and Pandey et al., 2004).

Results of previous research

Table 1: Total number of antibiotic producing actinomycetes

S.No.

Soil Sample from

Height

(m)

Total Actinomycetes isolates

Number of antibiotic producing isolates

1

Lukla

2660

14

9

2

Lobuche

5000-5300

12

7

3

Sagarmatha National Park

3446

14

-

4

Jorsale

2837

36

-

5

Tengboche

3867

8

-

6

Kalapattar

>5500

79

7 antibiotic producing actinomycetes screening out of 9 isolates.

7

Manang

3200-3600

45

45

Total

208

68

Out of these total antibiotic producing Actinomycetes, the following are the most potent strains producing broad spectrum antibiotics (inhibiting both Gram positive bacteria including Staphycoccus aureus, Bacillus subtilis and Gram negative bacteria including E.coli, Salmonella typhii, Salmonella paratyphii, Proteus vulgaris, Proteus mirabilis, Klebseilla pneumoniae, K. oxytoca, Shigella spp). But none of isolates were found to inhibit Pseudomanas spp used as test organism in our research.

Table 2: Total number of broad spectrum antibiotic producing Actinomycetes

Isolates from Kalapathar

1

K.6.3

2

K.14.2

3

K.58.5

4

K.8.2

5

K.16.4

6

K.60.4

Isolates from Manang

7

M30d

Isolates from Lobuche

8.

Lob18.2b

Expected Outcomes

Being majority of antibiotics producing bacteria are Actinomycetes (mainly Streptomyces spp.) our research work we will select different actinomycetes producing broad-spectrum antibiotics. The antibiotics will be partially purified and again bioassayed against the test organisms. The active fraction will be then analyzed for chemical characterization. Since these species are from very cold Everest region, the organisms as well as antibiotics produced by them may be novel ones.

References

Anderson AS and Wellington EMH (2001) The taxonomy of Streptomyces and related genera. Int J Syst Evol Microbiol 51:797–814

Busti E, Monciardini P, Cavaletti L, Bamonte R, Lazzarini A and Sosio et al. (2006) Antibiotic-producing ability by representatives of a newly discovered lineage of actinomycetes. Microbiology 152: 675-683

Holt JG 1989 Bergey's manual of systematic bacteriology, vol 4, ed. S.T. Williams and M.E. Sharpe, Baltimore, Md: Williams and Williams.

Kuster HJ, (1968) Uber die Bildung Von Huminstoffen durch Streptomyceten. Landwirtsch. Forsch 21:48-61

Nisbet LJ and Fox FM (1991) The importance of microbial biodiversity to biotechnology, In, The biodiversity of microorganisms and invertebrates: its role in sustainable Agriculture, ed.D.L. Hawksworth, 224-229, CAB International.

Pandey B, Ghimire P and Agrawal VP (2004) Studies on Antibacterial Activity of Soil from Khumbu Region of Mount Everest, a paper presented in International Conference on The Great Himalayas Climate, Health, Ecology, Management and Conservation, Kathmandu, January 12-15

Sahin N and Ugur A (2003) Investigation of the Antimicribial Activity of some Streptomyces isolates. Turk J Biol 27: 79-84.

Singh D and Agrawal VP (2002) Microbial Biodiversity of Mount Everest Region, a paper presented in International Seminar on Mountains - Kathmandu, March 6 – 8 (organized by Royal Nepal Academy of Science and Technology)

Singh D and Agrawal VP (2003) Diversity of Actinomycetes of Lobuche in Mount Everest I Proceedings of International Seminar on Mountains – Kathmandu: March 6 – 8, 2002 pp. 357 – 360.

Thangadural S, Shukla SK and Anjaneyulu Y (2002) Seperation and detecrion of certain β-lactan and fluoroquinolone antibiotic drugs by thin layer chromatography. Analytical Science 18: 97-100

Williams ST and Cross T (1971) Actinomycetes. In: J.R. Norris, D. W. Robbins, (eds), Methods in microbiology, vol.4. London, 295-334, Academic Perss, NewYork.

Bacteria in Photos

Bacteria in Photos